Skip to main content
. 2013 May 28;3(1):35–43. doi: 10.1007/s13554-013-0011-z

Fig. 2.

Fig. 2

Height data before and after switching to biosimilar recombinant human growth hormone in patients with different growth disturbances a Prader–Willi syndrome, b growth hormone deficiency, c Turner syndrome, d born small for gestational age, e other. Open circle originator rhGH, filled circle biosimilar rhGH